Article

Femtosecond laser receives FDA clearance

Advanced Medical Optics (AMO) has received FDA clearance for a fifth-generation femtosecond laser (iFS).

Santa Ana, CA-Advanced Medical Optics (AMO) has received FDA clearance for a fifth-generation femtosecond laser (iFS).

Capable of creating a corneal flap during the LASIK procedure in less than 10 seconds, according to the company, the laser has an inverted bevel-in, side-cut angle designed to ease the flap-lifting process, increase postoperative flap adhesion, and enhance the biomechanical stability of the cornea postoperatively. When customized, it also is capable of producing an elliptical flap.

Additional features of the laser, according to the company, include a higher repetition rate; tighter spot separation; lower energy; high-resolution digital video microscope; contemporary user interface, keyboard, and touch screen; and a design meant to be ergonomic.

Perry S. Binder, MD, of the Gordon Binder Weiss Vision Institute, San Diego, said, "The new . . . laser provides the surgeon with the ability to select LASIK flap dimensions customizable to individual refractive errors and corneal anatomy." Dr. Binder observed clinical trials of the laser and served as medical monitor for the technology prior to its clearance by the FDA.

The laser may be ordered now for shipment in the United States by the third quarter of this year.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.